ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

Официальное название

Physician Initiated Trial Investigating ESAR (EVAR Plus Heli-FX EndoAnchors) and FEVAR for the Treatment of Aortic Aneurysms With Short Infrarenal Aortic Neck

Обзор

The aim of this randomized study is to compare the safety and performance of EndoVascular Aneurysm Repair with ESAR using Endurant + Heli-FX™ EndoAnchor™ system and FEVAR using customizable grafts from Cook (Zenith Fenestrated Graft) and Terumo (Fenestrated Anaconda Graft) for the treatment of aortic aneurysms with short aortic neck (4 to 15mm).

Вмешательства

• Устройство ESAR treatment: Endograft + Heli-FX Endoanchor
  ESAR treatment: Endurant II or Endurant IIs endograft + Heli-FX Endoanchor
• Устройство FEVAR treatment : Fenestrated endograft
  Cook Zenith Fenestrated Graft or the Terumo Fenestrated Anaconda Graft

Первичные конечные точки

• Effectiveness Endpoint - Technical Success [Срок оценки: through 12 months post-procedure]
• Safety Endpoint - Freedom from Major Adverse Events [Срок оценки: through 30 days post-procedure]

Вторичные конечные точки (12)

• Total contrast volume (ml) at index procedure [Срок оценки: at index procedure]
• Total fluoroscopy time (minutes) at index procedure [Срок оценки: at index procedure]
• Duration (minutes) of index procedure [Срок оценки: at index procedure]
• Adequate penetration of EndoAnchor implants as assessed by the Core Lab [Срок оценки: at index procedure]
• Clinical success [Срок оценки: through 30 days post-procedure]
• Visceral artery patency or occlusion at 1, 12, 24 and 36 months follow-up [Срок оценки: through 1,12,24 and 36-months post-op]
• Freedom from type Ia and III endoleaks at 1, 12, 24 and 36 months follow-up [Срок оценки: through 1,12,24 and 36-months post-op]
• Freedom from aneurysm related secondary reinterventions at 1, 12, 24 and 36 months follow-up [Срок оценки: through 1,12,24 and 36-months post-op]
• Freedom from aneurysm related mortality at 1, 12, 24 and 36 months follow-up [Срок оценки: through 1,12,24 and 36-months post-op]
• Freedom from stent graft migration (>10mm change from 1-month follow-up imaging) at 12, 24 and 36 months follow-up [Срок оценки: through 12,24 and 36-months post-op]
• Sac dynamics (>5mm change from 1-month follow-up imaging): increase, stable, decrease at 12, 24, and 36 months follow-up [Срок оценки: through 12,24 and 36-months post-op]
• Freedom from conversion to open repair at 1, 12, 24 and 36 months follow-up [Срок оценки: through 1,12,24 and 36-months post-op]

Критерии участия

Критерии включения

• Subject is >18 years old
• Subject is scheduled for primary treatment of the abdominal aortic aneurysm with a non-aneurysmal infrarenal aortic sealing zone proximal to the aneurysm that is sufficiently healthy for a proximal neck length that is at least 4mm and not more than15 mm and has a circumferential minimum sealing zone length of 8 mm
• Subject is not a candidate for safe, effective and durable standard EVAR due to challenging anatomical criteria as confirmed by the Core Lab screening
• Subject is able and willing to comply with the protocol and to adhere to the follow-up requirements.
• Subject has provided written informed consent

CT Angiographic Inclusion Criteria

• Subject meets the other anatomical requirements according to the locally applicable Endurant II/IIs stent graft system, Heli-FX EndoAnchor system, Terumo Fenestrated Anaconda (available in EU only) and/or Cook Zenith Fenestrated Graft Instructions for Use
• Proximal neck length of the aorta within 4-15mm and a minimum circumferential sealing zone of 8mm
• Aortic neck diameter from 19 to 31mm
• Infrarenal neck angulation ≤45°

Критерии исключения

• Subject is participating in a concurrent study which may confound study results
• Subject has a life expectancy <2 year
• Subject is female of childbearing potential in whom pregnancy cannot be excluded
• Subject with eGFR <30 mL/min/m2 (KDOQI classification - exclude class IV and above) and or on dialysis
• Subject with a MI or CVA within 3 months prior to index procedure
• Subject with known Connective Tissue Disease
• Subject has a known hypersensitivity or contraindication to anticoagulants, antiplatelets, or contrast media, which is not amenable to post-treatment
• Subject who has undergone prior endovascular or open surgical treatment for abdominal aortic aneurysm
• Subject requires emergent aneurysm treatment, for example, trauma or rupture
• Subject has a known hypersensitivity or allergies to study device implant material
• Subject has an aneurysm that is:

• Suprarenal, pararenal, or thoracoabdominal
• Mycotic
• Inflammatory
• Pseudoaneurysm
• Subject is presenting with thrombus or calcification of the proximal aneurysm neck: circumferential >50%
• Pre-op stenosis of the renal arteries > 50%
• Subject has active infection or history of COVID-19. History of COVID-19 is defined as availability of positive COVID-19 test with sequelae or hospitalization for treatment of COVID-19.

Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.

Здоровые добровольцы: Нет

Дизайн исследования

Распределение

Рандомизированное

Модель

Параллельные группы

Маскирование

Открытое

Основная цель

Лечение

Центры проведения

США · 9 центров

• UCSD Medical Center Hillcrest — La Jolla
• Stanford University — Stanford
• University of Florida — Gainesville
• Corewell Health (Spectrum) — Grand Rapids
• Mount Sinai Hospital — New York
• Oklahoma Heart — Tulsa
• Providence Portland Medical Center — Portland
• Allegheny General Hospital — Pittsburgh
• … и ещё 1 центр

Италия · 6 центров

• University of Bologna, IRCCS S. Orsola Hospital, — Bologna
• Az. Ospedaliera San Martino, Genova — Genova
• IRCCS Ospedale San Raffaele, Chirurgia Vascolare — Milan
• Vascular Endovascular Surgery University of Perugia; — Perugia
• Az.Osped.Univers.S.Giovanni, Turin — Turin
• Azienda Ospedaliera Universitaria Integrata di Verona — Verona

Франция · 4 центра

• Amrois Paré Hospital (APHP) — Boulogne
• Service de Chirurgie Vasculaire et Endovasculaire CHU Gabriel-Montpied 58 rue Montalembert — Clermont-Ferrand
• Hospices Civils de lyon - Hôpital Edouard Herriot — Lyon
• Centre Hospitalier Universitaire de Rennes — Rennes

Германия · 4 центра

• University Hospital RWTH Aachen — Aachen
• University Hospital Leipzig — Leipzig
• Klinikum der Technischen Universität München — München
• Martin Austermann — Münster

Бельгия · 3 центра

• CRC thoracic Vascular Surgery, ZOL Genk — Genk
• Universitair Ziekenhuis Gent, Thoracale en vasculaire heelkunde — Ghent
• Jessa Ziekenhuis — Hasselt

Нидерланды · 2 центра

• VUMC Amsterdam — Amsterdam
• Catharina Ziekenhuis — Eindhoven

Испания · 2 центра

• Hospital Ramon Y Cajal — Madrid
• HOSPITAL CLINICO UNIVERSITARIO Valladolid — Valladolid

Австрия · 1 центр

• Hospital Ottakring, Institute for Vascular Surgery — Vienna

Польша · 1 центр

• National Institute of Cardiology Warzwa — Warsaw

Швейцария · 1 центр

• Inselspital Bern, Universitätsklinik für Gefässchirurgie — Bern

Идентификаторы

NCT: NCT04503395 · FCRE-191125

Первоисточники (государственные реестры)

• ClinicalTrials.gov (NIH, США)

Открыть это исследование на ClinicalTrials.gov ↗